HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy.

Abstract
Depending on increasing extracellular protein utilization and altering metabolic programs, cancer cells could proliferate and survive without restricion by ingesting human serum albumin (HSA) to serve as nutritional amino acids. Here, we hypothesize that the consumption of albumin by cancer cells could be utilized as an efficient approach to targeted drug delivery. Lidamycin (LDM), an antitumor antibiotic with extremely potent cytotoxicity to cultured cancer cells, consists of an apoprotein (LDP) and an active enediyne chromophore (AE). In the present study, a novel albumin-lidamycin conjugate was prepared by DNA recombination and molecular reconstitution. Results show that the IC50 values of albumin-lidamycin conjugate (HSA-LDP-AE) for a variety of tested cancer cells were at subnanomolar levels. At tolerated doses, the albumin-lidamycin conjugate significantly inhibited the growth of lung carcinoma PG-BE1 xenografts by 97.8%. The therapeutic efficacy of the albumin-lidamycin conjugate was much stronger than that of free lidamycin. Meanwhile, the images of albumin-lidamycin conjugate showed obvious and lasting tumor localization and fluorescence enrichment and there was no detectable signal in nontumor locations. Taken together, albumin-lidamycin conjugate, a new format of lidamycin, could be a promising antitumor therapeutic agent and albumin-integration might be a feasible approach to targeted antitumor drug delivery.
AuthorsLiang Li, Lei Hu, Chun-Yan Zhao, Sheng-Hua Zhang, Rong Wang, Yi Li, Rong-Guang Shao, Yong-Su Zhen
JournalBioconjugate chemistry (Bioconjug Chem) Vol. 29 Issue 9 Pg. 3104-3112 (09 19 2018) ISSN: 1520-4812 [Electronic] United States
PMID30105903 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Albumins
  • Aminoglycosides
  • Antibiotics, Antineoplastic
  • Enediynes
  • C 1027
Topics
  • Albumins (chemistry)
  • Aminoglycosides (chemistry, therapeutic use)
  • Animals
  • Antibiotics, Antineoplastic (chemistry, therapeutic use)
  • Cell Line, Tumor
  • Enediynes (chemistry, therapeutic use)
  • Female
  • Humans
  • Mice
  • Neoplasms (drug therapy)
  • Optical Imaging
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: